BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu JD, Wu YQ. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl) 2019;132:2229-36. [PMID: 31478927 DOI: 10.1097/CM9.0000000000000407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Perry JC, Schuetz TM, Memon MD, Faiz S, Cancarevic I. Anabolic Steroids and Cardiovascular Outcomes: The Controversy. Cureus 2020;12:e9333. [PMID: 32850208 DOI: 10.7759/cureus.9333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Kouidi EJ, Kaltsatou A, Anifanti MA, Deligiannis AP. Early Left Ventricular Diastolic Dysfunction, Reduced Baroreflex Sensitivity, and Cardiac Autonomic Imbalance in Anabolic-Androgenic Steroid Users. Int J Environ Res Public Health 2021;18:6974. [PMID: 34209901 DOI: 10.3390/ijerph18136974] [Reference Citation Analysis]
3 Gadela NV, Coban H, Wasserman E, Schreyer E, Jaiswal A. The Tragedy of a Strong Muscle and a Weak Heart: Complications of Anabolic-Androgenic Steroid Misuse. Cureus 2021;13:e17389. [PMID: 34584799 DOI: 10.7759/cureus.17389] [Reference Citation Analysis]
4 Nagata JM, Ganson KT, Cunningham ML, Mitchison D, Lavender JM, Blashill AJ, Gooding HC, Murray SB. Associations between legal performance-enhancing substance use and future cardiovascular disease risk factors in young adults: A prospective cohort study. PLoS One 2020;15:e0244018. [PMID: 33320903 DOI: 10.1371/journal.pone.0244018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Vítek L. (Doping, dietary supplements, and cardiovascular system). Cor Vasa 2020;62:419-22. [DOI: 10.33678/cor.2020.061] [Reference Citation Analysis]
6 Jin T, Wang L, Li D, Yang T, Zhou Y. Testosterone aggravates cerebral vascular injury by reducing plasma HDL levels. Open Life Sci 2020;15:1042-8. [PMID: 33817290 DOI: 10.1515/biol-2020-0107] [Reference Citation Analysis]
7 Collomp K, Ericsson M, Bernier N, Buisson C. Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences. Front Sports Act Living 2022;4:839976. [DOI: 10.3389/fspor.2022.839976] [Reference Citation Analysis]
8 Zahnow R, Mcveigh J, Bates G, Winstock AR. Motives and Correlates of Anabolic-Androgenic Steroid Use With Stimulant Polypharmacy. Contemporary Drug Problems 2020;47:118-35. [DOI: 10.1177/0091450920919456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
9 Smit DL, Grefhorst A, Buijs MM, de Hon O, den Heijer M, de Ronde W. Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse. Andrologia 2022;:e14372. [PMID: 35014715 DOI: 10.1111/and.14372] [Reference Citation Analysis]
10 Derakhshandeh M, Taghian F, Dehkordi KJ, Hosseini SA. Synchronized resistance training and bioactive herbal compounds of Tribulus Terrestris reverse the disruptive influence of Stanozolol. Steroids 2022. [DOI: 10.1016/j.steroids.2022.109000] [Reference Citation Analysis]
11 Alemany M. Estrogens and the regulation of glucose metabolism. World J Diabetes 2021; 12(10): 1622-1654 [PMID: 34754368 DOI: 10.4239/wjd.v12.i10.1622] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tasić T, Tadić M, Lozić M. Hypertension in Women. Front Cardiovasc Med 2022;9:905504. [DOI: 10.3389/fcvm.2022.905504] [Reference Citation Analysis]
13 Gagnon LR, Sadasivan C, Perera K, Oudit GY. Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology and Management. Can J Cardiol 2021:S0828-282X(21)00809-6. [PMID: 34737034 DOI: 10.1016/j.cjca.2021.10.008] [Reference Citation Analysis]
14 Lee JH, Jung EJ, Ham HJ, Yang YJ, Kim NS, Kim HI, Baek SY. Application of LC-MS/MS and UHPLC-Q-Orbitrap Methods for Determining 54 Steroids in illegal Dietary supplements and Other sample types. Rapid Commun Mass Spectrom 2022;:e9334. [PMID: 35705484 DOI: 10.1002/rcm.9334] [Reference Citation Analysis]
15 Adami PE, Koutlianos N, Baggish A, Bermon S, Cavarretta E, Deligiannis A, Furlanello F, Kouidi E, Marques-Vidal P, Niebauer J, Pelliccia A, Sharma S, Solberg EE, Stuart M, Papadakis M. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2022:zwab198. [PMID: 35081615 DOI: 10.1093/eurjpc/zwab198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
16 Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, Rosi GL, Di Nunno N, Salerno M, Montana A. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel) 2021;9:97. [PMID: 33477800 DOI: 10.3390/healthcare9010097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Zhou X, Münch G, Wohlmuth H, Afzal S, Kao M(, Al-khazaleh A, Low M, Leach D, Li CG. Synergistic Inhibition of Pro-Inflammatory Pathways by Ginger and Turmeric Extracts in RAW 264.7 Cells. Front Pharmacol 2022;13:818166. [DOI: 10.3389/fphar.2022.818166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sivalokanathan S, Małek ŁA, Malhotra A. The Cardiac Effects of Performance-Enhancing Medications: Caffeine vs. Anabolic Androgenic Steroids. Diagnostics (Basel) 2021;11:324. [PMID: 33671206 DOI: 10.3390/diagnostics11020324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Arjmand A, Abedi B, Hosseini SA. Anti-Apoptotic Effects of Resistance Training and Tribulus Terrestris Consumption in the Heart Tissue of Rats Exposed to Stanozolol. Eurasian J Med 2021;53:79-84. [PMID: 34177287 DOI: 10.5152/eurasianjmed.2021.20051] [Reference Citation Analysis]